Literature DB >> 14605508

Neuroleptic malignant syndrome in juvenile neuronal ceroid lipofuscinosis associated with low-dose risperidone therapy.

L Vercammen1, G M Buyse, J E F Proost, J L K Van Hove.   

Abstract

We present a patient with juvenile neuronal ceroid lipofuscinosis who developed a neuroleptic malignant syndrome when treated for hallucinations with a very low dose of risperidone, an atypical neuroleptic medication with usually few extrapyramidal side-effects. The loss of dopaminergic neurons in this condition may make these patients more vulnerable to this severe adverse effect.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605508     DOI: 10.1023/a:1025916518457

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  4 in total

Review 1.  Neurology of the neuronal ceroid-lipofuscinoses: late infantile and juvenile types.

Authors:  R M Boustany
Journal:  Am J Med Genet       Date:  1992-02-15

2.  Spectrum of mutations in the Batten disease gene, CLN3.

Authors:  P B Munroe; H M Mitchison; A M O'Rawe; J W Anderson; R M Boustany; T J Lerner; P E Taschner; N de Vos; M H Breuning; R M Gardiner; S E Mole
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

3.  Decreased striatal dopamine transporter density in JNCL patients with parkinsonian symptoms.

Authors:  L Aberg; K Liewendahl; P Nikkinen; T Autti; J O Rinne; P Santavuori
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

Review 4.  Pathogenesis of brain dysfunction in Batten disease.

Authors:  S U Walkley; P A March; C E Schroeder; S Wurzelmann; R D Jolly
Journal:  Am J Med Genet       Date:  1995-06-05
  4 in total
  3 in total

Review 1.  The neuropsychiatry of inborn errors of metabolism.

Authors:  Mark Walterfang; Olivier Bonnot; Ramon Mocellin; Dennis Velakoulis
Journal:  J Inherit Metab Dis       Date:  2013-05-23       Impact factor: 4.982

Review 2.  Neuroleptic malignant syndrome associated with atypical antipsychotic drugs.

Authors:  Julian N Trollor; Xiaohua Chen; Perminder S Sachdev
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 3.  Nosology and Phenomenology of Psychosis in Movement Disorders.

Authors:  Malco Rossi; Nicole Farcy; Sergio E Starkstein; Marcelo Merello
Journal:  Mov Disord Clin Pract       Date:  2020-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.